MENU
OABI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
OmniAb (OABI) Ownership - Who owns OmniAb?
OmniAb Inc offers therapeutic antibody discovery technologies... Show more
Profile
Industry
N/A
Address
5980 Horton Street
Phone
+1 510 250-7800
Employees
106
Web
https://www.omniab.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
218.62M
P/E Ratio
N/A
Total Cash
59.43M
Projected Growth
N/A
Total Debt
23.16M
Revenue
26.39M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.49
Total Debt/Equity
N/A
Revenue/Share
0.26 USD as % of share price
Fundamentals
OABI
Capitalization
219M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
59.4M
Total Cash/Share
0.49
Total Debt
23.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.26%
Revenue
26.4M
ROE
N/A
Book Value
288M
P/B Ratio
0.76
Cash Flow
N/A
Earnings
-0.61
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
4.52
Current Revenue Per Employee
94771.93
Dividends Per Share - Security
N/A
EBITDA
-50.92M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-17.70
Shares Held By Institutions
453M
Shares Outstanding - Current
122M
Total Liabilities
37.9M
Total Volume MTD
N/A
Value
1
Gain YTD
-49.435
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
5980 Horton Street
Phone
+1 510 250-7800
Employees
106
Web
https://www.omniab.com